BackCytek BioSciences Overview

Cytek BioSciences Profit Margin

Latest profit margin for Cytek BioSciences: -39.1% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-11.45%
↓ 9.34% YoY

As of Sep 2026

Annual Profit Margin (TTM)

-39.10%
↓ 500.37% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Cytek BioSciences (CTKB) FAQ

The latest profit margin for CTKB is -39.1% as of September 2026. That compares with -6.51% in the prior-year period — down 500.4% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside Cytek BioSciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, CTKB's profit margin moved from -6.51% to -39.1% — a 500.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cytek BioSciences's valuation or profitability profile.

Against Healthcare companies, CTKB currently prints -39.1% for profit margin, while the sector average sits near 17.63%. That is roughly 321.8% below the sector mean. Large gaps often invite a closer look at Cytek BioSciences's growth, margins, and balance sheet.

Profit Margin shows how effectively Cytek BioSciences converts resources into returns. At -39.1%, CTKB may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -6.51% in the prior-year period — down 500.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CTKB's profit margin (-39.1%), review year-over-year change from -6.51%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.